April 4th 2025
In a study recently presented at the American College of Cardiology (ACC) conference, researchers found that novice use of AI-guided cardiac ultrasound after an AI-enabled electrocardiogram increased the positive predictive value for reduced left ventricular ejection fraction (LVEF) or aortic valve stenosis by 33 percent.
November 20th 2024
Outpatient Reimbursement to Increase 65 Percent for EchoGo Heart Failure Platform in 2024
November 8th 2023Reimbursement for use of the artificial intelligence (AI)-powered EchoGo Heart Failure platform in hospital outpatient settings for Medicare and Medicaid patients is expected to increase from $99.81 to $284.88 in 2024.
Study Links PTSD to Higher Carotid Atherosclerosis and White Matter Hyperintensity in Midlife Women
November 6th 2023Ultrasound and MRI findings from a new study suggest that greater carotid atherosclerosis and elevated white matter hyperintensities among women with the APOEe4 genotype, a strong risk factor for Alzheimer’s disease, are associated with increased PTSD symptoms in midlife women.
GE HealthCare Adds Real-Time AI Guidance to Venue Family Ultrasound Systems
October 6th 2023Geared to clinicians who may lack ultrasound expertise, the artificial intelligence (AI)-powered Caption Guidance technology reportedly provides stepwise instruction for acquiring optimal cardiac ultrasound images.
Philips Unveils New Contrast-Enhanced Ultrasound Application for EPIQ Elite Device
September 8th 2023The Microvascular Imaging Super Resolution Contrast-Enhanced Ultrasound application reportedly leverages micro-bubble contrast media to provide enhanced spatial resolution for imaging of malignant lesions.
Viz.ai Gets FDA Nod for Hypertrophic Cardiomyopathy Module
August 16th 2023The De Novo approval for Viz HCM, which assesses electrocardiograms with artificial intelligence (AI) to identify possible cases of hypertrophic cardiomyopathy (HCM), is the 12th FDA clearance of algorithms on the Viz.ai Platform.
CMS Approves NTAP Reimbursement for AI-Powered EchoGo Heart Failure System
August 3rd 2023In what may represent the first CMS approval of a new technology add-on payment (NTAP) for an artificial intelligence (AI)-based heart failure detection platform, use of the EchoGo Heart Failure system will be eligible for up to $1,023.75 in NTAP reimbursement per acute hospital in-patient stay as of October 1, 2023.
Ultromics Gets HCPCS Code for AI-Powered EchoGo Heart Failure Device
July 6th 2023An artificial intelligence (AI)-enabled platform that can reportedly diagnose heart failure with preserved ejection fraction (HFpEF) through analysis of a single echocardiogram view, the EchoGo Heart Failure now has a HCPCS code for use of the technology in outpatient settings for Medicare beneficiaries.
Philips Set to Showcase Ultrasound Compact 5500CV at ASE Conference
June 22nd 2023The new portable ultrasound device, which is being showcased at the American Society of Echocardiography (ASE) conference, offers enhanced cardiac imaging as well as shared transducer interoperability and workflows with existing EPIQ CVx and Affiniti CVx ultrasound systems.
Could Controlled Imaging Rein in Suboptimal Use of MRI, CT and Ultrasound Exams?
April 24th 2023Lamenting a lack of control over imaging requests from referring clinicians, this author suggests that a more collaborative approach between referrers and radiologists may facilitate more efficient use of imaging.